Seeking value primarily in the non-US developed markets

The international value portfolio is constructed from an equity universe composed of companies with market capitalizations typically greater than $1 billion located throughout the non-US developed and emerging market countries. Through rigorous, bottom-up company analysis, we seek to identify undervalued stocks with upside potential. The investment process comprises three stages: quantitative screening and initial analysis, fundamental research and portfolio construction.

Benchmark
MSCI EAFE
Inception
June 11, 2001
Download Profile Sheet Download Flash Report Download Quarterly Review Risk Disclosures
Contact Us

Strategy overview

The portfolio managers discuss our International Value strategy.

Portfolio managers

Fundamental Portfolio Manager
Fundamental Portfolio Manager
President
Head of Fundamental Research
Fundamental Portfolio Manager
Chief Executive Officer
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager

Performance

Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 2.8%33.0%31.5%22.6%14.4%9.8%8.8%
Strategy (net) 2.8%32.6%31.0%22.1%14.0%9.4%8.3%
MSCI EAFE 1.8%28.0%25.1%16.7%9.8%8.3%6.4%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 2.8%33.0%31.5%22.6%14.4%9.8%8.8%
Strategy (net) 2.8%32.6%31.0%22.1%14.0%9.4%8.3%
MSCI EAFE 1.8%28.0%25.1%16.7%9.8%8.3%6.4%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 6.4%29.4%19.2%28.9%18.1%10.1%8.7%
Strategy (net) 6.3%29.0%18.7%28.5%17.7%9.6%8.3%
MSCI EAFE 4.8%25.7%15.6%22.3%11.7%8.7%6.4%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 6.4%29.4%19.2%28.9%18.1%10.1%8.7%
Strategy (net) 6.3%29.0%18.7%28.5%17.7%9.6%8.3%
MSCI EAFE 4.8%25.7%15.6%22.3%11.7%8.7%6.4%
Fund 20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Strategy (gross) 5.9%29.0%-7.2%10.5%6.1%22.5%-18.0%28.6%1.1%-1.9%-4.6%27.6%24.6%-10.2%13.9%37.7%-43.0%9.8%27.5%9.0%29.5%48.4%-8.9%
Strategy (net) 5.5%28.5%-7.6%10.1%5.6%22.0%-18.4%28.0%0.7%-2.3%-5.0%27.1%24.1%-10.5%13.4%37.1%-43.2%9.4%27.0%8.5%29.0%47.8%-9.2%
MSCI EAFE 4.3%18.9%-14.0%11.8%8.3%22.7%-13.4%25.6%1.5%-0.4%-4.5%23.3%17.9%-11.7%8.2%32.5%-43.1%11.6%26.9%14.0%20.7%39.2%-15.7%
Table Header
Strategy (gross)
Strategy (net)
MSCI EAFE
20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
5.9%29.0%-7.2%10.5%6.1%22.5%-18.0%28.6%1.1%-1.9%-4.6%27.6%24.6%-10.2%13.9%37.7%-43.0%9.8%27.5%9.0%29.5%48.4%-8.9%
5.5%28.5%-7.6%10.1%5.6%22.0%-18.4%28.0%0.7%-2.3%-5.0%27.1%24.1%-10.5%13.4%37.1%-43.2%9.4%27.0%8.5%29.0%47.8%-9.2%
4.3%18.9%-14.0%11.8%8.3%22.7%-13.4%25.6%1.5%-0.4%-4.5%23.3%17.9%-11.7%8.2%32.5%-43.1%11.6%26.9%14.0%20.7%39.2%-15.7%

Portfolio (as of November 30, 2025)

Benchmark: MSCI EAFE
Asset Allocation
Table Header Strategy
Stocks 97.5%
Cash 2.5%
Strategy Characteristics
Table Header Strategy Benchmark
No. of holdings 67 694
Weighted avg. market cap (US $MM) $85,660 $89,733
FY2 price/earnings 12.9 15.0
Price/book value 1.7 2.2
Dividend yield (%) 2.5 2.8
TOP 10 HOLDINGS
Security Country Percent
Kering SA France 5.3%
AstraZeneca PLC United Kingdom 3.7%
Alstom SA France 3.5%
Roche Holding AG Switzerland 3.1%
Reckitt Benckiser Group Plc United Kingdom 3.1%
Barclays PLC United Kingdom 3.1%
Renesas Electronics Corp. Japan 3.0%
Samsung Electronics Co., Ltd. South Korea 2.5%
BNP Paribas SA France 2.5%
Compagnie de Saint-Gobain SA France 2.4%

A “weighted average” measures a characteristic by the market capitalization of each stock. Price/book ratio is the weighted average of the price/book ratios of all the stocks in a portfolio. The P/B ratio of a company is calculated by dividing the market price of its stock by the company’s per-share book value. The price/earnings ratio is the weighted average of the price/earnings ratios of the stocks in a portfolio. The FY2 P/E ratio is a forward P/E ratio using a next-twenty-four months EPS estimate in the denominator.

Holdings are subject to change.

SECTOR WEIGHTS
Sector Strategy Benchmark
Financials 18.1% 24.4%
Industrials 16.5% 19.1%
Health Care 13.1% 11.5%
Information Technology 13.0% 8.5%
Consumer Discretionary 10.0% 10.0%
Consumer Staples 9.2% 7.6%
Materials 6.6% 5.4%
Communication Services 4.8% 4.6%
Utilities 3.2% 3.7%
Energy 2.0% 3.2%
Real Estate 1.1% 1.9%
TOP 10 COUNTRIES
Country Strategy Benchmark
United Kingdom 27.4% 14.8%
France 19.7% 10.8%
Japan 11.5% 22.7%
Germany 8.8% 9.6%
Netherlands 6.5% 5.0%
South Korea 3.8% 0.0%
United States 3.4% 0.0%
Switzerland 3.1% 9.5%
Italy 2.6% 3.2%
Belgium 2.4% 1.1%
Regional Allocation
  • Euro 40.0%
  • Europe - Other 34.0%
  • Pacific 12.4%
  • North America 5.7%
  • Emerging Asia 5.1%
  • Emerging Europe, Middle East, Africa 0.4%

Commentary (As of November 30, 2025)

Highlights

  • Global equity markets were broadly flat for November, but style performance diverged, with value stocks outperforming growth in certain regions.
  • Market trends in 2025 year-to-date point to a notable shift in investor sentiment and capital rotation toward non- US equity markets.
  • We are investing in companies with, in our view, durable pricing power, strong brands, and resilient product pipelines, and we view periods of temporary underperformance as opportunities to build positions at compelling valuations.

Portfolio Attribution

The Portfolio outperformed the Index during the month, due primarily to stock selection. Portfolio holdings in the capital goods, telecommunication services, and banks industry groups contributed to relative performance. Holdings in the consumer durables & apparel and consumer services industry groups, along with an overweight position in the technology hardware & equipment industry group, offset some of the outperformance compared to the Index. The top contributor to return was pharmaceuticals & biotechnology company, Roche Holding AG (Switzerland). Other notable contributors included pharmaceutical company, AstraZeneca PLC (United Kingdom), and banking & financial services company, BNP Paribas SA (France). The largest detractor was electronic equipment manufacturer, Samsung Electronics Co., Ltd. (South Korea). Additional notable detractors included multinational luxury conglomerate, Kering SA (France), and cruise ship operator, Carnival Corp. (United States).

Investment Outlook

Market trends in 2025 year-to-date point to a notable shift in investor sentiment and capital rotation toward non-US equity markets. European fund inflows accelerated in the first half of the year, helping fuel the 12% appreciation of the euro versus the US dollar through the end of November. Year-to-date, US dollar weakness accounts for much of the outperformance of international markets. This strong developed international equity outperformance in US-dollar terms has likely renewed investor interest in undervalued European, UK, and Japanese equities.

The current rise of international value indices over growth provides a constructive backdrop for our value-oriented investment style. Among the leading non-US sectors in 2025, we see continued upside potential in financials, industrials, information technology, and consumer staples. Several of the portfolio’s lagging stocks this year appear well-positioned to outperform in 2026 as management teams execute on earnings and cash-flow improvements, inspiring market confidence.

Tariffs continue to weigh on China; despite a recent slowdown in overall fixed-asset investment, we currently expect resilient capital investment for high-tech and advanced manufacturing, including electronics, new energy vehicles, pneumatics and automation, batteries, grid electrification, data centers, and aerospace. Several portfolio companies in Japan and Europe appear positioned to benefit from this structural investment trend.

We are investing in companies with, in our view, durable pricing power, strong brands, and resilient product pipelines, and we view periods of temporary underperformance as opportunities to build positions at compelling valuations. We aim to hold management teams accountable for accelerating operational restructuring and improving shareholder returns. We remain confident that active management and disciplined stock selection should continue to uncover attractive opportunities across global markets.

The market commentary expresses the portfolio managers’ views as of the date of this report and should not be relied on as research or investment advice regarding any stock. These views and the portfolio holdings and characteristics are subject to change. There is no guarantee that any forecasts made will come to pass. The securities identified and described above do not represent all of the securities purchased, sold or recommended for client accounts. The reader should not assume that an investment in the securities identified was or will be profitable. Past performance does not guarantee future results. For a description of our performance attribution methodology, or to obtain a list showing every holding's contribution to the overall account's performance during the quarter, please contact our product manager, Kevin Moutes, at 310-231-6116 or [email protected].